UK-based Enough Food, which manufactures mycoprotein, raised €42m in their latest investment round. Food Strategy Associates (FSA) provided vendor support to Enough Food.
“FSA have unique capabilities, strong networks and deep knowledge in the sector. We appointed them to support specific market analysis and to model the market structure for B2B plant-based solutions”Jim Laird, CEO of Enough Food
Robert Lawson, Managing Partner Food Strategy Associates and experienced in the plant based sector for over two decades said, “In the rapidly growing plant-based market, fermented mycoprotein has a substantial role to play. Enough Food offers the opportunity for much wider market access for mycoprotein, both to manufacturers and consumers across the world.”
Mycoprotein is the ingredient produced and used in the largest meat substitute brand globally. This investment in Enough Food will allow other manufacturers to access the ingredient which is highly competitive compared to popular legume-based meat substitutes in terms of health and environmental credentials, cost, and taste.
Notes to Editors
Food Strategy Associates Europe LLP operates a unique hybrid model of industry expertise and consulting rigour to provide strategic advice on the food manufacturing and food packaging sectors to those operating within the industry and to those seeking to invest in it, both across European and North American markets. FSA has been growing rapidly since 2012 with Partners bringing over 200 years of global food industry and 150 years of consulting blue-chip experience supported by significant and expanding analytical capability.
Please contact Robert Lawson on [email protected] or 07810 756957 for all media enquiries.